FI964212A0 - X-ray contrast agent containing pharmaceutically acceptable clays - Google Patents

X-ray contrast agent containing pharmaceutically acceptable clays

Info

Publication number
FI964212A0
FI964212A0 FI964212A FI964212A FI964212A0 FI 964212 A0 FI964212 A0 FI 964212A0 FI 964212 A FI964212 A FI 964212A FI 964212 A FI964212 A FI 964212A FI 964212 A0 FI964212 A0 FI 964212A0
Authority
FI
Finland
Prior art keywords
pharmaceutically acceptable
contrast agent
agent containing
ray contrast
containing pharmaceutically
Prior art date
Application number
FI964212A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI964212A (en
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John Toner
Edward R Bacon
Tom Caulfield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of FI964212A0 publication Critical patent/FI964212A0/en
Publication of FI964212A publication Critical patent/FI964212A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI964212A 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays FI964212A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
FI964212A0 true FI964212A0 (en) 1996-10-18
FI964212A FI964212A (en) 1996-10-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964212A FI964212A (en) 1994-04-21 1996-10-18 X-ray contrast compositions containing pharmaceutically acceptable clays

Country Status (9)

Country Link
EP (1) EP0756497A1 (en)
JP (1) JPH09512029A (en)
CN (1) CN1147206A (en)
AU (1) AU1897795A (en)
CA (1) CA2187019A1 (en)
FI (1) FI964212A (en)
HU (1) HUT76304A (en)
NO (1) NO964451L (en)
WO (1) WO1995028969A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (en) * 2003-06-10 2011-04-13 味の素株式会社 Composition for gastrointestinal imaging in CT colonography
KR100783255B1 (en) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 Androgen receptor modulators
JP2007532621A (en) 2004-04-13 2007-11-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Androgen modulator
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
WO2006006065A1 (en) 2004-07-08 2006-01-19 Warner-Lambert Company Llc Androgen modulators
CN1330380C (en) * 2005-03-18 2007-08-08 山东师范大学 X-ray contrast agent composition and its preparation method
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
EP3984560A1 (en) 2013-03-15 2022-04-20 The Regents of the University of California Enteric ct contrast material based on low-z atoms
CN117018234A (en) 2013-08-16 2023-11-10 加利福尼亚大学董事会 Silicone-based intestinal CT contrast material
CN106075476B (en) * 2016-07-30 2019-05-31 温州市人民医院 A kind of contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (en) * 1954-01-08 1959-05-15 Schering Corp Use as radiopaque agents of polyiodinated phenoxy fatty acids
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
EP0756497A1 (en) 1997-02-05
WO1995028969A1 (en) 1995-11-02
HU9602908D0 (en) 1996-12-30
JPH09512029A (en) 1997-12-02
AU1897795A (en) 1995-11-16
NO964451D0 (en) 1996-10-18
NO964451L (en) 1996-12-18
CA2187019A1 (en) 1995-11-02
HUT76304A (en) 1997-07-28
MX9604899A (en) 1998-03-31
FI964212A (en) 1996-10-18
CN1147206A (en) 1997-04-09

Similar Documents

Publication Publication Date Title
NO972409D0 (en) dose indicating
PL305701A1 (en) Pharmaceutical agent
FI971279A (en) Drug
DE69517317D1 (en) MEDICAL TUBE
DE69423024T2 (en) X-ray machine
DK0769017T3 (en) Therapeutic compounds
DE69505926D1 (en) X-ray tube assemblies
DK0630039T3 (en) X-ray
FI945312A0 (en) Description-layer X-ray machine
FI964212A0 (en) X-ray contrast agent containing pharmaceutically acceptable clays
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
DE9421296U1 (en) X-ray machine
DE69512984D1 (en) X-RAY UNIT
FI952725A (en) Radiographic Unit
NO954695D0 (en) Iodine boron compounds suitable as X-ray contrast agents, and pharmaceutical compounds thereof
DE9410948U1 (en) Therapeutic pillow
DE59510194D1 (en) can
DE29509710U1 (en) X-ray protection for patients
GB9407726D0 (en) Pharmaceutical agent
NO962816D0 (en) Pharmaceutical compounds
DE9405255U1 (en) Can
DE9415360U1 (en) Can
DE29619689U1 (en) Medical therapeutic agent
KR960012525U (en) X-ray holder structure
BR9302334A (en) Urovarginal for patients

Legal Events

Date Code Title Description
FD Application lapsed